Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC (CYTK), sold 4,500 shares at $65.21 ($293K) on 2026-04-07, disclosed to the SEC on 2026-04-08.
Seasonal sale ($293k) by EVP Research & Development — this insider has traded CYTK in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.75 | 1,000 | $65K | 22.1% |
| 2 | $65.21 | 3,500 | $228K | 77.9% |
| Total | $65.11 avg | 4,500 | $293K | 100% |
| Filing → |
| CYTK | SELL | 2026-09-08 | $264K | — | Filing → |
| CYTK | SELL | 2026-08-18 | $265K | — | Filing → |
| CYTK | SELL | 2026-07-23 | $282K | — | Filing → |